Finance

Lists
Why is GANX down 3.70%?
Dive Deeper
GANX:NASDAQ
Gain Therapeutics Inc
$1.04
-3.70%
(-0.040) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GANX...
Open
$1.12
High
$1.14
Low
$1.01
Mkt. cap
46.31M
Avg. vol.
529.90K
Volume
328.88K
52-wk high
$4.34
52-wk low
$0.96
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.12
High
$1.14
Low
$1.01
Mkt. cap
46.31M
Avg. vol.
529.90K
Volume
328.88K
52-wk high
$4.34
52-wk low
$0.96
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to GANX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for GANX in the last 3 months.
Highest
Current $1.04
$8.00 (+669.23%)
Average
$6.25 (+500.96%)
Lowest
$5.00 (+380.77%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
$5.00
+380.8%
11/12/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$8.00
+669.2%
11/12/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$7.00
+573.1%
11/10/2026
Thomas Shrader
BTIG
Buy
Maintained
$5.00
+380.8%
11/10/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$8.00
+669.2%
08/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
2.32M
2.74M
2.12M
-
Cost of revenue
2.32M
2.74M
2.12M
-
Research and development expenses
-
-
-
1.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.15M
2.61M
2.56M
1.78M
Operating expense
2.15M
2.61M
2.56M
3.20M
Total operating expenses
4.47M
5.35M
4.68M
3.20M
Operating income
-4.47M
-5.35M
-4.68M
-3.20M
Other non operating income
-
-
-
-
EBT including unusual items
-4.47M
-5.43M
-4.57M
-3.09M
EBT excluding unusual items
-4.47M
-5.43M
-4.57M
-3.09M
Income tax expense
70.12K
183.07K
104.07K
72.49K
Effective tax rate
-1.57%
-3.37%
-2.28%
-2.35%
Other operating expenses
-
-
-
-
Net income
-4.54M
-5.61M
-4.68M
-3.16M
Net profit margin
-
-
-
-
Earnings per share
-0.11
-0.13
-0.11
-0.07
Interest and investment income
88.58K
93.34K
60.73K
41.96K
Interest expense
-
-
-
-
Net interest expenses
88.58K
93.34K
60.73K
41.96K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.46M
-5.34M
-4.67M
-3.16M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps